Iowa HF701 mandates a review of anti-obesity medications by the Department of Health and Human Services for the medical assistance program.

Iowa HF701 requires the Department of Health and Human Services to review anti-obesity medications for effectiveness, impact on comorbidities, and potential cost savings. The review must also consider eligibility requirements for the medical assistance program. The department must submit a report to the general assembly by December 1, 2025, detailing findings and proposed eligibility requirements.

Iowa HF701 mandates a review of anti-obesity medications by the Department of Health and Human Services for the medical assistance program.

Iowa HF701 requires the Department of Health and Human Services to review anti-obesity medications for effectiveness, impact on comorbidities, and potential cost savings. The review must also consider eligibility requirements for the medical assistance program. The department must submit a report to the general assembly by December 1, 2025, detailing findings and proposed eligibility requirements.